Ken Herrmann sold $77K of AKTS stock

Ken Herrmann, Dir of Aktis Oncology, Inc. (AKTS), sold 3,065 shares of AKTS stock worth $77K, per an SEC Form 4 filed Jul 20, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 17, 2026, 3 days before it was made public.

AKTS has moved -29.9% since the trade date, from $24.89 to $17.45 (Nov 10, 2026 close).